IHC 4 Markers Classification | Lahalak Platform
A package combining accurate diagnosis and predictive assessment via 4 biomarkers to estimate recurrence likelihood and develop an evidence-based treatment and follow-up plan.
Scientific name: Immunohistochemistry (IHC) Interpretation and Consultation (4 Markers)
A systematic diagnostic-predictive consultation package is based on the analysis and integration of results from four carefully selected immunohistochemical (IHC) markers, according to standard guidelines. The package typically combines two or three diagnostic/classification markers with one predictive/proliferative marker (at least one, such as Ki...
Service type
Medical Consultation (Tissue Analysis)
Duration
30-45 minutes
Fasting
Fasting is not required
Included Services
- A comprehensive review and analysis of the results of four immunohistochemical (IHC) markers, focusing on the integration of diagnostic and diagnostic markers.
- Applying standard risk classification algorithms (by tumor type) to the resulting tetrad pattern.
- Consult a specialist pathologist to interpret the overall results.
- Issuing a unified diagnostic-predictive report summarizing the diagnosis, level of risk, and treatment and follow-up recommendations.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- Identify the four signs: They must be clearly stated, with reference to any sign that is considered a "risk regulator" (e.g., Ki-67).
- Reporting: Attach all four laboratory reports.
- Key clinical information: It is necessary to include the tumor stage if known, because the risk classification is often different between early and late stages.
- No need for new samples or fasting.
- Expected duration: 5 to 10 working days.
Medical services you might also like